Moderna, Inc Equity-NMS: MRNA

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$26.93
Open :$26.34
Today's high :$26.81
Today's low :$25.6
52W low :$23.15
52W high :$158.82
EPS(TTM): :-8.5
Shares O/S :386.74 M
Market cap :10.27 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Moderna, Inc $26.56 +0.06% - 10.27B

Frequently Asked Questions

What is the share price of Moderna, Inc today?

Moderna, Inc (MRNA) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Moderna, Inc

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).